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Abstract
We analyzed the ability of two rat coronavirus (RCoV) strains, sialodacryoadenitis virus (SDAV) and Parker's RCoV (RCoV-P), to infect rat
alveolar type I cells and induce chemokine expression. Primary rat alveolar type II cells were transdifferentiated into the type I cell phenotype.
Type I cells were productively infected with SDAV and RCoV-P, and both live virus and UV-inactivated virus induced mRNA and protein
expression of three CXC chemokines: CINC-2, CINC-3, and LIX, which are neutrophil chemoattractants. Dual immunolabeling of type I cells
for viral antigen and CXC chemokines showed that chemokines were expressed primarily by uninfected cells. Virus-induced chemokine
expression was reduced by the IL-1 receptor antagonist, suggesting that IL-1 produced by infected cells induces uninfected cells to express
chemokines. Primary cultures of alveolar epithelial cells are an important model for the early events in viral infection that lead to pulmonary
inflammation.
© 2007 Elsevier Inc. All rights reserved.Keywords: Alveolar epithelium; Chemokine; Sialodacryoadenitis virus; Parker rat coronavirus; CINC-2; CINC-3; LIX; Neutrophil chemoattractant; IL-1 receptor
antagonistIntroduction
The large surface area of the alveolar epithelium makes it an
important interface between respiratory pathogens and the host.
Alveolar type I cells, whichmake up 95% of this surface area, are
terminally differentiated and function in gas exchange and fluid
homeostasis (Williams, 2003). Alveolar type II cells are dividing
cells that transdifferentiate in vivo into the type I cell phenotype
during the repair of damaged alveolar epithelium. Type II cells
also produce surfactant proteins and lipids, which keep the
alveoli expanded and function in innate defense of the lung
(Evans et al., 1975; Mason, 2006). Epithelial cells that line the
respiratory tract initiate pulmonary inflammation in response to
pollutants, allergens, or infectious agents (Martin et al., 1997).⁎ Corresponding author. Fax: +1 303 724 4226.
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doi:10.1016/j.virol.2007.07.030Bronchial epithelial cells and alveolar type II cells express and
secrete proinflammatory cytokines and chemokines in response
to infection with respiratory viruses including respiratory syn-
cytial virus, influenza A virus, and the SARS-associated
coronavirus (SARS-CoV) (Chan et al., 2005; Yen et al., 2006;
Zhang et al., 2001). The role of alveolar type I cells in immune
responses to viral infection is largely unknown.
Coronaviruses are an important cause of respiratory infec-
tions of animals, humans, and birds. Five coronaviruses are
known to cause respiratory disease in humans. Human
coronaviruses (HCoVs) 229E and OC43 are etiologic agents
of the common cold and can cause more serious lower
respiratory tract disease in elderly or immunocompromised
patients (Birch et al., 2005; Pene et al., 2003). Infection with
SARS-CoV was associated with an epidemic of severe acute
respiratory syndrome in 2002–2003 that had a case fatality rate
of ∼10% (Ksiazek et al., 2003; Tsui et al., 2003). HCoV-NL63
and HCoV-HKU1 are recently identified coronaviruses that are
associated with both upper and lower respiratory tract diseases in
children and adults (Fouchier et al., 2004; Kuypers et al., 2007;
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Coronaviruses also cause respiratory diseases in rats, dogs,
cows, pigs, and poultry (Weiss and Navas-Martin, 2005).
Several strains of rat coronavirus (RCoV) have been isolated
from the lungs of rats with clinical or subclinical infections
(Compton et al., 1999; Kojima and Okaniwa, 1991; Parker et al.,
1970). The two prototype strains of RCoV have different tissue
tropisms and disease associations in rats. Sialodacryoadenitis
virus (SDAV) causes disease primarily in the upper respiratory
tract, salivary and lacrimal glands, and eyes (Bhatt et al., 1972;
Jacoby et al., 1975). SDAV has also been isolated from the lower
respiratory tract and can cause mild interstitial pneumonia in
young rats (Wojcinski and Percy, 1986). In contrast, Parker's
RCoV (RCoV-P) has only been isolated from the respiratory
tract and causes fatal pneumonia in suckling rats (Bhatt and
Jacoby, 1977; Parker et al., 1970). In adult rats inoculated
intranasally with RCoV-P, virus replicates in the upper and lower
respiratory tracts. Neutrophils are observed in the nasal cavity,
trachea, and alveoli on days 2–5, followed by infiltration of
mononuclear cells in the lung on day 5 after infection. RCoV-P
infection of adult rats causes interstitial pneumonia and focal
edema in the alveoli, which resolves by day 8 after infection
(Bhatt and Jacoby, 1977). As with RCoV-P, upon intranasal
inoculation of adult rats with SDAV, neutrophils are the primary
infiltrating cell type in the respiratory epithelium early in
infection (Jacoby et al., 1975; Wojcinski and Percy, 1986).
RCoV is an important model in which to study the pathogenesis
of pulmonary infection caused by a coronavirus in its natural
host. Here we examine the role of alveolar type I cells in the
innate immune response to rat coronavirus infection.
Primary cultures of rat alveolar epithelial cells are a well-
characterized model of differentiated lung epithelium, which
have not been studied previously with respect to viral infection
(Wang et al., 2006). Alveolar type II cells isolated from rat lung
can be cultured in vitro to either maintain the type II cell
phenotype or transdifferentiate into the type I cell phenotype
(Dobbs et al., 1985, 1988; Mason et al., 2002; Nishina et al.,
2005). Because alveolar type I cells are difficult to isolate at a
high yield and purity, transdifferentiated type II cells are used as
a model to study the characteristics and functions of type I cells
in vitro (Borok et al., 1998a; Dobbs et al., 1985;Williams, 2003).
After 3–5 days in culture on plastic in the absence of rat serum
and keratinocyte growth factor (KGF), rat alveolar type II cells
change in morphology from a cuboidal to a flattened shape, and
have decreased expression of surfactant proteins and lamellar
bodies and increased expression of the type I cell markers, T1α,
aquaporin V, and caveolin-1 (Borok et al., 1998a, 1995, 1998b;
Danto et al., 1995; Manzer et al., 2006; Mason et al., 2002).
In this study, cultures of rat alveolar type I cells were
evaluated for susceptibility to RCoV infection, and for
expression and secretion of proinflammatory cytokines and
chemokines in response to RCoV inoculation. To our knowl-
edge, this is the first study to evaluate the in vitro response of rat
alveolar epithelial cells to infection with a rat virus. Two strains
of RCoV, RCoV-P and SDAV, caused productive infection of
alveolar type I cells. Infection of type I cell cultures with these
coronaviruses increased expression and secretion of CXCchemokines, CINC-2, CINC-3, and LIX, which are important
neutrophil chemoattractants. Secretion of these chemokines was
also induced by UV-inactivated viruses, showing that viral re-
plication was not required for the induction of chemokine
expression. Dual immunolabeling of viral antigen and CXC
chemokines showed that expression of CXC chemokines was
primarily from uninfected cells in these cultures. Virus-induced
chemokine expression was reduced by IL-1 receptor antagonist,
but not soluble TNF receptor, indicating that IL-1 produced by
infected cells may induce chemokine expression from the
uninfected type I cells. These data suggest that alveolar type I
cells can secrete chemokines in response to viral infection,
which may lead to infiltration of neutrophils into the lung.
Results
Rat coronavirus strains RCoV-P and SDAV infect primary
cultures of rat alveolar type I cells
Type I cells infected with RCoV-P showed mild cytopathic
effects including cell rounding and vacuolation at 24 h after
inoculation (Fig. 1). Type I cells infected with SDAV had more
pronounced cytopathic effects including syncytia formation and
cell detachment. No cytopathic effects were observed in mock-
inoculated type I cell cultures. At 24 h after virus inoculation,
viral nucleocapsid protein was detected in type I cells inoculated
with RCoV-P or SDAV, but not in mock-inoculated cells.
Culture media from type I cells inoculated with RCoV-P or
SDAV were collected at various times after inoculation and
titrated by plaque assay. RCoV-P and SDAV replicated with
similar kinetics in alveolar type I cells (Fig. 2). Infectious virus
was first detected in the supernatant medium by 12 h after
inoculation, and reached a maximum titer of 105–106 PFU/ml at
24 h.
Infection of alveolar type I cells by RCoV-P or SDAV induces
expression of pro-inflammatory chemokines
Culture media from type I cells collected 6 h or 24 h after
inoculation with sucrose density gradient purified RCoV-P or
SDAV were assayed for the presence of 19 rat cytokine and
chemokine proteins by protein macroarray analysis (Fig. 3). At
6 h after inoculation, both RCoV-P- and SDAV-inoculated type I
cells showed increased secretion of the chemokines CINC-2,
CINC-3 (CXCL-2/3, MIP-2), fractalkine (CX3CL-1), GM-CSF,
IFN-γ, LIX (CXCL-5), Leptin, and MIP-3α (CCL20), com-
pared to mock-inoculated cells. By 24 h after inoculation,
CINC 2, CINC-3, fractalkine, LIX, MIP-3α, and TNF-α were
increased in cultures that were inoculated with each of these
viruses. Infection of type I cells with SDAV increased the
expression of several other cytokines, including IL-1α, IL-1β,
IL-4, IL-6, and IL-10, compared to mock or RCoV-P inoculated
cultures.
Because CINC-2, CINC-3, and LIX are closely related CXC
chemokines that are expressed by rat alveolar epithelial cells in
response to LPS or cytokines (Jeyaseelan et al., 2005; Manzer
et al., 2006; Nishina et al., 2005; Vanderbilt et al., 2003), we
Fig. 2. Growth curves of RCoV-P and SDAV replication in alveolar type I cells.
Type I cells were inoculated with RCoV-P or SDAVat an MOI of 2. Media were
harvested at the indicated times after inoculation and titrated by plaque assay on
L2P-41.a cells. Data shown are averages from duplicate experiments.
Fig. 1. Cytopathic effects and viral antigen expression in alveolar type I cells
infected with RCoV-P or SDAV. Live cells were photographed at 10×
magnification 24 h after inoculation with RCoV-P, SDAV, mock inoculation,
or exposure to UV-inactivated RCoV-P or SDAV. Arrowheads point to
cytopathic effects in the virus-inoculated cells. To visualize viral antigen, cells
were fixed 24 h after inoculation with virus and immunolabeled for viral
nucleocapsid antigen using a FITC-conjugated secondary antibody. Nuclei were
stained with DAPI. Representative fields from 6 experiments are shown.
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infected type I cells. The expression of CXC chemokines, CINC-
2, CINC-3, and LIX, was confirmed by quantitative RT-PCR and
ELISA (Fig. 4). Infection of type I cells with RCoV-P or SDAV
induced expression of mRNA encoding CINC-2α, CINC-3, and
LIX at 6 h and 24 h after inoculation (Fig. 4A). Infection with
RCoV-P or SDAV also induced secretion of CINC-2, CINC-3,
and LIX proteins by 6 h after inoculation (Fig. 4B). Secretion of
the CXC proteins increased further at 24 h and 48 h after
inoculation. The ELISA for CINC-2 did not differentiate
between CINC-2α and CINC-2β, whereas the probe used in
RT-PCR was specific for CINC-2α. Rat alveolar type I cells do
not express CINC-2β constitutively or in response to cytokines
or ozone (Nishina et al., 2005; Wang et al., 2006).UV-inactivated virus also induces expression of CINC-2,
CINC-3, and LIX
To determine whether viral replication was required to
induce CXC chemokine expression, we inactivated the in-
fectivity of RCoV-P and SDAV by UV irradiation. Inactivation
of virus infectivity was confirmed by plaque assay of the UV-
treated viral inoculum or medium from type I cells 24 h after
exposure to UV-treated virus, in comparison to untreated virus.
The titers of UV-treated RCoV-P and SDAV were below the
limit of detection of our plaque assay (11.1 PFU/ml). Alveolar
type I cells exposed to UV-treated virus for 24 h did not express
viral nucleocapsid protein (Fig. 1), but nevertheless induced
secretion of CINC-2, CINC-3, and LIX compared to mock-
inoculated type I cells (Fig. 5). There was no difference in the
amount of CXC chemokines secreted from type I cells treated
with UV-inactivated virus compared to cells treated with
infectious virus (pb0.05).
To determine whether the CXC chemokine response to in-
fectious or UV-inactivated RCoV-P or SDAV was specific for
the rat coronaviruses, we inoculated rat alveolar type I cells with
a related group 2a coronavirus, mouse hepatitis virus (MHV)
strain A59 that had been purified by sucrose density gradient
centrifugation. No viral antigen was detected by immunolabel-
ing at 24 h after inoculation of type I cells with MHV-A59, and
the expression of CXC chemokines CINC-2, CINC-3, and LIX
was not increased compared to mock-inoculated cells (data not
shown).
Uninfected cells in the type I cultures express CXC chemokines
To determine whether the increase in CXC chemokine ex-
pression in alveolar type I cell cultures was limited to virus-
infected cells, at 16 h after virus inoculation type I cell cultures
were treated with brefeldin A for 6 h before dual immunolabel-
ing of viral nucleocapsid protein and CXC chemokines (Fig. 6).
Brefeldin A inhibits export of secreted proteins from the distal
Fig. 3. Protein macroarray analysis of cytokine and chemokine secretion from alveolar type I cell cultures infected with RCoV-P or SDAV. Type I cells were inoculated
with RCoV-P, SDAV, or mock inoculated. Media were harvested at (A) 6 h or (B) 24 h after inoculation and incubated with RayBio membrane arrays as directed by the
manufacturer. Representative membranes from duplicate experiments are shown. Densitometry data were normalized to internal positive controls on each membrane
and graphed as relative units. Open bars=Mock, hatched bars=RCoV-P, black bars=SDAV. Scans of autoradiographs for each membrane are inset with relevant spots
boxed with numbers corresponding to cytokines on the graph.
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the ELISA data, cultures of type I cells that had been inoculated
with RCoV-P or SDAV had increased immunolabeling with
CINC-2, CINC-3, and LIX antibodies compared to mock
inoculated cultures. CINC-2 and LIX were much more brightly
labeled than CINC-3 (data not shown), corresponding to the
concentrations of protein detected by ELISA (Fig. 4B). The
majority of cells that were positive for CXC chemokine
expression did not express viral nucleocapsid protein. Therefore,
the ELISA data showing increased chemokine secretion in
RCoV-infected type I cell cultures is mostly from uninfected
cells. These data suggest that RCoVs induce CXC chemokine
expression in type I cell cultures through an indirect mechanism.Signaling through the IL-1 receptor, but not the TNF receptor,
promotes SDAV-induced CXC chemokine expression in rat
alveolar type I cells
To test the hypothesis that a paracrine factor secreted from
infected cells induces CXC chemokine expression in uninfected
cells in the culture, we analyzed the ability of antagonists for the
IL-1 and TNF receptors to block the CXC chemokine response.
The IL-1 receptor antagonist (IL-1ra) binds strongly to the IL-1
type I receptor, thereby preventing signal transduction by IL-1α
and IL-1β (Dinarello, 1996). The TNF soluble receptor protein
(TNFsrp) binds to both soluble and membrane-bound forms of
TNF-α, thereby inhibiting their activity (Dinarello, 2005).
Fig. 4. CXC chemokines have increased levels of mRNA and protein in alveolar type I cells infected with RCoV-P or SDAV. Type I cells were inoculated with RCoV-P,
SDAV, or mock-inoculated. Total cellular RNAwas extracted at 6 h and 24 h after inoculation. (A) mRNA expression for CINC-2α, CINC-3, and LIX was evaluated
by quantitative RT-PCR as described in Materials and methods. Asterisks (∗) indicate a significant difference compared to mock at the same time point, pb0.05. (B)
Media from type I cell cultures were analyzed by ELISA at 6 h, 24 h, and 48 h after inoculation for the expression of CINC-2, CINC-3, and LIX. Asterisks (∗) indicate
significant difference from mock-inoculated cells at the same time point, pb0.01. All data are average values of duplicate samples from 3 to 6 experiments.
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level of CINC-2, CINC-3, and LIX secretion when it was added
to type I cells prior to inoculation and maintained in the medium
throughout infection with SDAV (Fig. 7). The presence of
TNFsrp had no effect on the chemokine secretion during SDAV
infection of type I cells. When both IL-1ra and TNFsrp were
present during SDAV infection, the levels of CINC-2, CINC-3,
and LIX expression were the same as levels from cells that were
treated with IL-1ra alone. These data suggest that IL-1 that is
secreted from infected alveolar type I cells induces expression of
CXC chemokines in uninfected cells in the culture.
Discussion
Although type I cells make up 95% of the surface area of the
alveolar epithelium, their role in the pathogenesis of respiratory
virus infections and in innate immunity is largely unknown. In
this study, we evaluated the ability of rat coronaviruses to infect
rat alveolar type I cells in vitro. Despite differences in tissue
tropism and disease association in vivo, two strains of RCoVwere able to infect primary alveolar epithelial cells in vitro. We
showed that infection of alveolar type I cells with either RCoV-P
or SDAV induced expression of chemokines, CINC-2, CINC-3,
LIX, MIP-3α, and fractalkine at both 6 h and 24 h after
inoculation. Our protein array analysis also identified cytokines
that are increased in SDAV-infected, but not RCoV-P-infected,
alveolar type I cell cultures. This differential cytokine response
may play a role in the different pathogenesis of RCoV-P and
SDAV infections in vivo. Fractalkine, the sole member of the
CX3C chemokine family, is predominately a membrane-bound
chemokine and functions in the recruitment and adhesion of
cytotoxic lymphocytes to endothelial cell surfaces (Stievano
et al., 2004). MIP-3α, which is chemotactic for dendritic cells, B
cells, and memory T cells, is expressed by human bronchial
epithelial cells in response to inflammatory mediators IL-1β and
TNF-α (Starner et al., 2003).
Previous studies showed that alveolar type II cells express
CXC chemokines both constitutively and in response to treat-
ment with cytokines, LPS, or acid and infection with Pseudo-
monas aeruginosa (Gonzalez et al., 2005; Jeyaseelan et al.,
Fig. 5. UV-inactivated viruses induce secretion of chemokines from alveolar
type I cells. Type I cells were inoculated with RCoV-P or SDAV, mock-
inoculated, or treated with UV-inactivated RCoV-P or SDAV (see Fig. 1). Media
were harvested 24 h after treatment and chemokine secretion was analyzed by
ELISA. Asterisks (∗) indicate significant difference from mock-inoculated cells,
pb0.05. Data are average values of duplicate samples from 3 experiments.
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Our study contributes to the growing body of data that supports a
role for alveolar type I cells in chemokine expression (Manzer
et al., 2006; Wang et al., 2006). CXC chemokines are important
mediators of neutrophil chemotaxis and immunopathology
associated with respiratory virus infections (Londhe et al.,
2005; Tumpey et al., 2005; Turner, 1990; Yen et al., 2006; Zhang
et al., 2001). Therefore, we further quantified the expression of
CXC family members CINC-2, CINC-3, and LIX made by rat
alveolar type I cells in response to RCoV infection by
quantitative RT-PCR and ELISA. Levels of CINC-2, CINC-3,
and LIXmRNAs and secreted proteins were increased in RCoV-
infected type I cell cultures. CINC-2, CINC-3, and LIX areclosely related CXC-ELR+ chemokines that are similar to IL-8/
CXCL8 in humans (Shibata et al., 1995; Smith et al., 2002).
CINC-2, CINC-3, and LIX specifically bind and signal through
CXCR2, a seven transmembrane domain receptor expressed on
rat type II alveolar cells, endothelial cells, and neutrophils
(Chandrasekar et al., 2003; Dunstan et al., 1996; Shibata et al.,
2000; Vanderbilt et al., 2003). Neutrophil chemotaxis and
activation are the primary functions of CXCR2 signaling.
However, CXCR2 also mediates cellular proliferation and
morphogenesis, angiogenesis, and wound healing (Devalaraja
et al., 2000). CXC chemokines secreted from infected alveolar
epithelial cells could potentially signal through CXCR2 on type
II pneumocytes to stimulate type II cell proliferation and trans-
differentiation into the type I cell phenotype, resulting in repair
of damaged epithelium. Expression of CXCR2 and secretion of
CXC chemokines are upregulated in alveolar type II cells by
lung injury (Vanderbilt et al., 2003). In addition, CINC-1 sig-
naling through CXCR2 on type II cells promotes alveolar
development in newborn rats that are exposed to hyperoxic
conditions (Auten et al., 2001). CXC chemokine signaling
through CXCR2 on alveolar type II cells and endothelial cells
may also promote retraction of these cells, which would promote
increased migration of neutrophils and other inflammatory cells
into the alveoli (Schraufstatter et al., 2001). Although CINC-2,
CINC-3, and LIX signal through the same receptor, they may
have some distinct functions during viral infection. For example,
although CINC-2 and CINC-3 have similar neutrophil chemo-
tactic activity, CINC-3 induces greater calcium mobilization
than CINC-2, resulting in increased neutrophil activation
(Shibata et al., 2000). Further studies are needed to elucidate
the roles of CINC-2, CINC-3, and LIX in the innate immune
response to RCoV infection in vivo.
The production of CXC chemokines by alveolar epithelial
cells during viral infection is probably responsible for the
recruitment of neutrophils to the infected alveoli, an early event
in a variety of respiratory viral infections. Respiratory viruses,
including influenza Avirus, rhinovirus, and respiratory syncytial
virus (RSV), induce expression of CXC chemokines, which
results in an influx of neutrophils into the respiratory tract (Abu-
Harb et al., 1999; Tumpey et al., 2005; Turner, 1990;Wang et al.,
1998; Zhang et al., 2001; Zhu et al., 1997). Infiltration of
neutrophils into lung and other tissues occurs soon after
infection with coronaviruses including rat coronaviruses,
mouse hepatitis virus strains 1 and JHM, and SARS-CoV, and
has been implicated in both immunopathology and virus
clearance (Bhatt and Jacoby, 1977; De Albuquerque et al.,
2006; Haagmans et al., 2004; Iacono et al., 2006; Tsui et al.,
2003; Yen et al., 2006; Zhou et al., 2003). After intranasal
inoculation of adult rats with RCoV-P, neutrophils are found in
the upper respiratory tract on day 2 and in the lung on day 5,
corresponding to the presence of viral antigen and histological
lesions (Bhatt and Jacoby, 1977). Neutrophils are also the
earliest infiltrating cell type in the respiratory epithelium after
intranasal inoculation with SDAV (Jacoby et al., 1975;
Wojcinski and Percy, 1986). The role of neutrophils in RCoV
clearance and immunopathology is not yet known. Primary
cultures of alveolar epithelial cells are an important model in
Fig. 6. Virus infection induces expression of chemokines from uninfected type I cells in the culture. Type I cells were treated with brefeldin A 16 h after inoculation
with SDAVand fixed 6 h later. Fixed cells were immunolabeled for expression of viral nucleocapsid protein (red) and CINC-2 or LIX (green). Nuclei were stained blue
with DAPI. Representative fields from duplicate experiments are shown.
294 T.A. Miura et al. / Virology 369 (2007) 288–298which to study the early events in viral infection that lead to
pulmonary inflammation.
Like infection with RCoV-P or SDAV, other UV-inactivated
viruses also induce expression of CXC chemokines. UV-in-
activated murine coronavirus, MHV-4 variant V5A13.1, induces
expression of CXC and CC chemokine genes in primary mouse
astrocyte cultures and in the CNS of infected mice during acute
and chronic phases of CNS disease (Lane et al., 1998). UV-
inactivated RSVor soluble viral glycoproteins (F andG proteins)
induce expression of IL-8 in A549 cells (Tirado et al., 2005). Our
data show that a component of purified virions that was not
destroyed by UV light was responsible for inducing chemokine
expression. The viral hemagglutinin esterase glycoprotein (HE)
was not required for the induction of CXC chemokines because
SDAV virions do not contain HE (Gagneten et al., 1996; MiuraFig. 7. There is decreased expression of CINC-2, CINC-3, and LIX in SDAV-infected
1ra, TNFsrp, or both proteins and inoculated with SDAV. After 1 h, the inoculum was
receptor antagonists. After 18 h the media were analyzed for CXC chemokines by EL
infected cells without receptor antagonist treatment and SDAV-infected cells with
experiments with triplicate samples.and Holmes, unpublished observation). Perhaps interaction of
the viral spike glycoprotein with as yet unknown cellular re-
ceptor(s) triggers chemokine expression, as SARS-CoV spike
protein does in A549 cells (Chang et al., 2004). Alternatively,
other viral structural proteins may induce expression of
chemokines (Law et al., 2007; Tirado et al., 2005). For several
RNA viruses, dsRNA replicative intermediates induce chemo-
kine expression (Hewson et al., 2005; Imaizumi et al., 2004;
Londhe et al., 2005). However, this is unlikely to be the case for
RCoV because viral replication was not required for chemokine
expression.
Viral infection can induce chemokine expression either by a
direct or indirect mechanism (Melchjorsen et al., 2003). In our
RCoV-infected type I cell cultures, dual immunolabeling of
viral antigen and CXC chemokines demonstrated that the CXCtype I cells that have been treated with IL-1ra. Type I cells were treated with IL-
removed, cells were rinsed and refed with medium with or without the indicated
ISA. Asterisks (*) indicate a statistically significant difference between SDAV-
receptor antagonist treatment (pb0.05). Data are representative of duplicate
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express viral nucleocapsid protein. This suggests that RCoV
infection of alveolar type I cells can indirectly induce ex-
pression of chemokines in uninfected cells. Infected cells may
release a soluble factor such as IL-1 or TNF-α, which could
stimulate nearby cells to express and secrete CXC chemokines
(Manzer et al., 2006; Nishina et al., 2005). To test this
hypothesis, we inoculated type I cells with SDAV in the
presence of antagonists for the IL-1 and/or TNF receptors, IL-
1ra and TNFsrp, respectively. Treatment with IL-1ra, but not
TNFsrp, decreased CXC chemokine secretion from SDAV-
infected cultures (Fig. 7). Thus, signaling through the IL-1
receptor contributes to the induction of CXC chemokine
expression in SDAV-infected type I cell cultures.
IL-1ra blocks signaling of both IL-1α and IL-1β through the
IL-1 receptor (Dinarello, 1996). IL-1 is important in the
induction of CXC chemokines in lung cells in vitro and in
vivo. Both IL-1α and IL-1β induce expression and secretion of
CXC chemokines in primary cultures of rat alveolar type I and
type II cells (Manzer et al., 2006; Nishina et al., 2005;
Unpublished observations). Furthermore, IL-1 receptor knock-
out mice have a decreased neutrophil response to influenza
infection, likely due to decreased IL-1-dependent expression of
CXC chemokines (Schmitz et al., 2005).
A potential limitation of this study is that we isolated type II
cells and transdifferentiated them into a type I-like cell
phenotype in vitro (Manzer et al., 2006; Wang et al., 2006).
While transdifferentiated type I cells express T1α and many
other type I cell markers, are morphologically like type I cells,
and secrete MIP-2 and MCP-1 in response to LPS and IL-1,
they may not express all of the genes expressed in freshly
isolated type I cells (Gonzalez et al., 2005; Manzer et al., 2006;
Wang et al., 2006). Although we think that it is unlikely, it is
possible that type I cells in vivo will respond differently to viral
infection.
Animal models to evaluate the mechanisms of viral induction
of chemokines in the lung are valuable in studying viral
pathogenesis and designing treatments for viral diseases. The
expression of chemokines in SARS patients has been correlated
with increased disease severity (Tang et al., 2005). SARS
pathogenesis has been studied in rodent models: aged mice,
SARS-CoV adapted to cause disease in rodents, or transgenic
mice that express the SARS receptor, human angiotensin
converting enzyme 2 (McCray et al., 2007; Nagata et al.,
2007; Roberts et al., 2007, 2005; Tseng et al., 2007). We are
studying rat coronaviruses as amodel for respiratory coronavirus
infection in the natural host of the virus. The study of other
rodent viruses in their natural hosts has advanced the under-
standing of other respiratory viral pathogens, such as Sendai
virus and pneumonia virus of mice as models for human
parainfluenza and RSV respectively (Faisca and Desmecht,
2007; Rosenberg et al., 2005). Recently the MHV-1 strain of
murine coronavirus was shown to induce severe respiratory
disease in mice andwas proposed as amodel for SARS-CoV (De
Albuquerque et al., 2006). Primary cultures of rat alveolar
epithelial cells will be a valuable model for dissecting the virus-
cell interactions and innate immune responses that are importantin the critical early steps in pulmonary infection of a virus in its
natural host.
Materials and methods
Isolation and culture of alveolar epithelial cells
Alveolar type II cells were isolated from 6–8-week-old,
specific pathogen-free male Sprague–Dawley rats (Harlan
Sprague Dawley, Indianapolis, IN) as previously described
(Dobbs and Mason, 1979; Manzer et al., 2006). Briefly, type II
cells were dissociated from rat lung with porcine pancreatic
elastase (Roche Molecular Biochemicals, Indianapolis, IN) and
were partially purified on discontinuous Optiprep (Axis-Shield
Poc As, Oslo, Norway) density gradients. Cells were plated on
plastic tissue culture dishes in DMEM supplemented with 5%
FBS, 2 mM glutamine, 2.5 ug/ml amphotericin B, 100 ug/ml
streptomycin, and 100 ug/ml penicillin G, and incubated at 37 °C
and 10% CO2. Culture of type II cells on plastic in DMEM
containing 5% FBS for 3–5 days results in trans-differentiation
into the type I cell phenotype, characterized by loss of expression
of surfactant proteins, gain of expression of T1α and aquaporin
V, and changes in morphology and lectin-binding specificities
(Borok et al., 1998a, 1995, 1998b; Danto et al., 1995; Dobbs
et al., 1985; Manzer et al., 2006; Wang et al., 2006).
Viruses
RCoV-P and SDAV were obtained from Dr. D. Percy (Uni-
versity of Guelph, Guelph, Ontario) (Percy et al., 1991). Viruses
were propagated in a subclone of murine L929 cells, L2P-41.a
(Gagneten et al., 1996), purified by sucrose density gradient
ultracentrifugation as previously described, and stored in TMS
buffer (25 mM Tris, 25 mMmaleic acid, 100 mMNaCl, pH 6.5)
with 5% glycerol (Sturman et al., 1980). Viral titers were deter-
mined by plaque assay on L2P-41.a cells (described below).
Purified virus was diluted in DMEM to achieve equivalent doses
of RCoV-P and SDAV for inoculation. For experiments with
UV-inactivated viruses, the diluted viruses were exposed on ice
to UV irradiation in a Stratalinker UV Crosslinker (Stratagene,
La Jolla, CA) at a cumulative dose of 120 mJ/cm2. Inactivation
of virus was demonstrated by plaque assay of the UV-irradiated
virus and medium from type I cells 24 h after inoculation with
the UV-irradiated virus, as well as by immunofluorescent
detection of viral antigens in type I cells 24 h after inoculation
with the UV-irradiated virus, using a cross-reactive mAb to the
mouse hepatitis virus nucleocapsid protein (described below).
These analyses confirmed that the infectivity of the RCoVs was
completely eliminated by this UV treatment. UV-irradiated viral
inocula were shown to be free of bacterial contamination by
inoculation of blood agar and incubation at 37 °C.
Viral infection of alveolar type I cells
Primary alveolar epithelial cells were cultured as described
above for 5 days to obtain a type I cell phenotype, then
inoculated with RCoV-P, SDAV, UV-inactivated RCoV-P or
296 T.A. Miura et al. / Virology 369 (2007) 288–298SDAV, or mock inoculated. After a 1 h adsorption period, the
cells were washed twice with DMEM, refed with DMEM/5%
FBS and antibiotics, and incubated at 37 °C and 10% CO2. For
mock inoculation of alveolar type I cells, TMS buffer with 5%
glycerol was diluted in DMEM at the same ratio as the virus
inoculum. Twenty-four hours after inoculation, type I cells on
coverslips were fixed in methanol/acetic acid (3:1). Viral
nucleocapsid antigen was detected using a monoclonal antibody
to mouse hepatitis virus nucleocapsid protein (kindly provided
by Dr. J. Leibowitz, Texas A&M University, College Station,
TX) that cross-reacts with RCoV nucleocapsid protein, followed
by a FITC-conjugated goat anti-mouse secondary antibody
(Jackson ImmunoResearch Laboratories, Inc., West Grove, PA).
At intervals after inoculation, media from inoculated cultures
were collected for viral titration, cytokine protein arrays and
ELISAs. Total cellular RNAwas extracted for quantification of
chemokine mRNA as described below. For experiments with
receptor antagonists, IL-1ra (10 ug/ml), TNFsrp (10 ug/ml),
neither antagonist, or both IL-1ra and TNFsrp were added to
type I cells 30 min prior to inoculation with SDAV. The con-
centration of antagonist was maintained in the culture through-
out the 18 h infection. IL-1ra and TNFsrp were kindly provided
by Dr. Charles Dinarello (University of Colorado Health
Sciences Center, Denver, CO).
Plaque assay
Stocks of purified virus or medium from virus infected
cultures was serially diluted in DMEMwithout FBS and used to
inoculate triplicate wells of near confluent L2P-41.a cells. After
a 1 h adsorption period at 37 °C, the inoculum was removed and
the cells were overlaid with MEM, 4% FBS, antibiotics, and
0.5% SeaKem LE agarose (Cambrex, Rockland, ME). Plaques
were stained after 72 h incubation at 37 °C, with the agarose
overlay medium containing 6% neutral red (Sigma-Aldrich).
Cytokine protein array
Type I cells were inoculated with RCoV-P or SDAV, or were
mock-inoculated as described above. Media from type I cells
were collected 24 h after inoculation, centrifuged to remove
cellular debris, and incubated with membranes spotted with
antibodies specific for 19 rat cytokines and chemokines
(RayBiotech, Inc., Norcross, GA). The membranes were pro-
cessed according to the manufacturer's recommendations. The
membranes were exposed to X-ray film and the film was
scanned for densitometry analysis using Kodak Molecular
Imaging Software (Eastman Kodak Company, Rochester, NY).
Densitometry data were normalized to internal positive controls
on each membrane and graphed as relative units.
Real-Time quantitative RT-PCR
Total RNA was isolated from alveolar epithelial cells using
Trizol reagent according to the manufacturer's specifications
(Invitrogen Corp., Carlsbad, CA). Reverse transcription and
TaqMan PCR (Applied Bioscience) were performed on an ABIPrism 7700 sequence detection system as previously described
(Wang et al., 2006), using published primer pairs and fluoro-
genic probes for CINC-2α (Wang et al., 2006), CINC-3 (Nishina
et al., 2005), and LIX (Jeyaseelan et al., 2005). The mRNA
expression levels of CINC-2, CINC-3, and LIXwere normalized
to the level of GAPDH mRNA for each sample, using a com-
mercially available rat GAPDH kit (Applied Bioscience).
Enzyme linked immunosorbent assay (ELISA)
Media from RCoV-inoculated or mock-inoculated alveolar
type I cells were harvested 6, 24, and 48 h after inoculation for
the measurement of CINC-2, CINC-3, and LIX by ELISA.
ELISA assays were developed by ELISAtech (Aurora, CO)
using standards and antibodies from R&D Systems (Minneapo-
lis, MN). The CINC-2β antibody (R&D Systems) used in the
ELISA shows significant cross-reactivity to CINC-2α, hence the
product of this ELISA is referred to as CINC-2. Chemokine
levels were quantified by comparison of values with that of a
standard curve for each chemokine. The reported values are
averages ± standard error of the mean of at least three
independent experiments with two replicate wells per experi-
ment. The chemokine concentrations were compared between
samples using one-way ANOVA. P values were computed using
the Newman–Keuls multiple comparison test.
Dual immunolabeling of viral antigen and CXC chemokines
Type I cells were inoculated with RCoV-P or SDAV, or were
mock-inoculated. After 18 h, a protein transport inhibitor that
contained brefeldin A (BD GolgiPlug, BD Biosciences) was
added to the culture medium as recommended by the manu-
facturer. Six hours later, the cells were fixed with 2% parafor-
maldehyde and permeabilized with 0.2% Triton X-100 (Sigma
Aldrich). Viral nucleocapsid protein was detected using a
monoclonal antibody to MHV nucleocapsid (described above)
followed by an Alexafluor 594-conjugated anti-mouse second-
ary antibody (Invitrogen). CXC chemokines were detected with
goat antibodies (R&D Systems) to rat LIX (AF543), CINC-3
(AF525), or CINC-2α (AF516) followed by an Alexafluor
488-conjugated anti-goat secondary antibody (Invitrogen).
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